首页 产品目录 分子砌块 按官能团 试剂 (R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-二羟基-9-(羟甲基)-4,4,13,14-四甲基-3,11-二氧代-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基)-6-羟基-2-甲基-5-氧代庚-3-烯-2-基乙酸酯

(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-二羟基-9-(羟甲基)-4,4,13,14-四甲基-3,11-二氧代-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基)-6-羟基-2-甲基-5-氧代庚-3-烯-2-基乙酸酯

(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
5mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

6040-19-3

中文名称

(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-二羟基-9-(羟甲基)-4,4,13,14-四甲基-3,11-二氧代-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊二烯并[a]菲-17-基)-6-羟基-2-甲基-5-氧代庚-3-烯-2-基乙酸酯

英文名称

(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

别名

Cucurbitacin A;(10α,23E)-25-(Acetyloxy)-2β,16α,20-trihydroxy-9β-(hydroxymethyl)-19-norlanosta-5,23-diene-3,11,22-trione;2,16,20,25-Tetrahydroxy-9-(hydroxymethyl)-19-norlanosta-5,23-diene-3,11,22-trione 25-acetate;Cucurbitacine A;NSC 94743;Cucurbit A;(2S,4R,9beta,16alpha,23E)-2,16,20-trihydroxy-9-(hydroxymethyl)-10,14-dimethyl-1,11,22-trioxo-4,9-cyclo-9,10-secocholesta-5,23-dien-25-yl acetate;19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-(hydroxymethyl)-, (2β,9β,10α,16α,23E)-

标准英文名

(R,E)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

MDL No.

-

分子式

C32H46O9

分子量

574.71

精确分子量

574.31

SMILES

CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)C(=O)C4(C)C)[C@]3(CO)C(=O)C[C@]12C

标准SMILES

CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)C(=O)C4(C)C)[C@]3(CO)C(=O)C[C@@]21C

用途

Cucurbitacin A is used in the treatment of primary liver cancer. Clinical observations from six hospitals in Shanghai, Beijing, Guangxi, and other regions involving 169 cases showed an overall efficacy rate of 69% and a marked efficacy rate of 39%. Clinical data indicate that, compared with 5-fluorouracil, Cucurbitacin A demonstrates superior performance in alleviating symptoms, relieving hepatic pain, reducing tumor size, prolonging survival, and restoring physical strength, without the typical toxic side effects associated with conventional chemotherapeutic agents.

InChIKey

IHTCCHVMPGDDSL-IVNGUWCNSA-N

安全信息

SureRoute逆合成路线

1.  6040-19-3 逆合成路线 1

—
—
ACIDYI472
6040-19-3
来源: SureRoute

2.  6040-19-3 逆合成路线 2

—
—
ACIDYI472
6040-19-3
来源: SureRoute

3.  6040-19-3 逆合成路线 3

—
—
ACIDYI472
6040-19-3
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手